tiprankstipranks
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
US Market

Amicus (FOLD) Income Statement

Compare
990 Followers

Amicus Income Statement

Last quarter (Q4 2024), Amicus's total revenue was $149.71M, an increase of 30.09% from the same quarter last year. In Q4, Amicus's net income was $14.74M. See Amicus’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 528.29M$ 399.36M$ 329.23M$ 305.51M$ 260.89M
Gross Profit
$ 475.35M$ 362.03M$ 290.63M$ 271.05M$ 229.84M
Operating Expenses
$ 450.48M$ 427.65M$ 495.06M$ 470.97M$ 473.70M
Depreciation and Amortization
$ 8.55M$ 7.87M$ 5.34M$ 6.21M$ 8.85M
EBITDA
$ 29.39M$ -92.08M$ -199.58M$ -202.87M$ -242.98M
Operating Income
$ 24.88M$ -73.49M$ -204.43M$ -199.92M$ -243.85M
Other Income/Expenses
$ -53.63M$ -76.61M$ -37.61M$ -41.63M$ -30.40M
Pretax Income
$ -28.76M$ -150.10M$ -242.04M$ -241.55M$ -274.25M
Net Income
$ -56.11M$ -151.58M$ -236.57M$ -250.46M$ -276.85M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.18$ -0.51$ -0.82$ -0.92$ -1.07
Diluted EPS
$ -0.18$ -0.51$ -0.82$ -0.92$ -1.07
Weighted Average Shares Outstanding
304.38M 295.16M 289.06M 271.42M 258.87M
Weighted Average Shares Outstanding (Diluted)
304.38M 295.16M 289.06M 271.42M 258.87M
Currency in USD

Amicus Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis